Uronefron pills p/o №10×6

Name:
Uronefron tab. cover captivity. about. in bl. in pack. No. 10×6
Description:
round-shaped tablets with a biconvex surface, film-coated, dark green color Release form Film-coated tablets Pharmacological properties Pharmacodynamics Uronefron is a combined drug containing components of plant origin as active substances. Pharmacokinetics No data available, the drug contains various biologically active substances. Indications for use In the complex therapy of urinary tract diseases (urethritis, cystitis). Use for the indicated purposes is based on long-term experience only. Dosage and administration Apply inside adults. Take after meals 1 tablet 3-4 times a day. Patients with impaired renal function Dose adjustment may be necessary for patients with impaired renal function, depending on the degree of impaired renal function. Patients with impaired liver function No information available. The duration of the course of treatment is determined by the doctor, taking into account the characteristics of the disease, the effect achieved and the tolerability of the drug. Precautions Before using the drug, a doctor’s consultation is necessary. When using the drug, glycemic control is necessary in patients with diabetes mellitus due to the possible hypoglycemic effect of fenugreek. If you have an intolerance to some sugars, talk to your doctor before taking this medicine as it contains lactose monohydrate. Due to the lactose content, the drug is not recommended for patients with galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome. If you experience pain, difficulty urinating, blood in your urine, worsening symptoms, or fever, you should contact your doctor immediately. During the use of the drug, it is recommended to drink plenty of fluids. Do not use the drug in case of edema caused by heart or kidney failure. Children. Due to the lack of sufficient data, the drug is not recommended for use in children under 18 years of age. Use during pregnancy or lactation. Due to the lack of sufficient data, the drug is not recommended for use during pregnancy or lactation. The ability to influence the reaction rate when driving vehicles or working with other mechanisms. If dizziness occurs during treatment with the drug, you should refrain from driving and working with mechanisms. Interaction with other drugs Due to the diuretic effect, accelerated elimination of other drugs that are used in complex therapy is possible. May enhance the effect of hypoglycemic drugs, non-steroidal anti-inflammatory drugs, MAO inhibitors, anticoagulants. Prolongs the action of pentabarbital, paracetamol, amidopyrine. Reduces the absorption of beta-carotene, alpha-tocopherol, cholesterol in the small intestine. If you are taking other medicines at the same time, you should consult your doctor. ContraindicationsIncreased individual sensitivity to the components of the drug or to plants of the aster family (Asteraceae or Compositae), umbellate (Apiaceae or Umbelliferae), birch pollen or anethole; acute glomerulonephritis; acute interstitial nephritis; nephrosis; phosphate lithiasis; diseases in which it is necessary to restrict fluid intake (for example, renal or heart failure). Obstruction of the urinary tract. Conditions accompanied by increased blood clotting. Pregnancy, lactation, children under 18 years of age. Active ingredients: 1 tablet contains 188 mg of dry extract from 9 plants (DER (4-5): 1): dry extract from medicinal plant materials (onion peel (Allium cepa) 5.0%, birch leaves (Betula alba) 10.0%, couch grass (Agropyron repens) 12.5%, curly root parsley (Petroselium sativum) 17.5%, fenugreek seeds (Trigonella foenum graecum) 15.0%, common goldenrod herb (Solidago virgaurea) 5 , 0%, horsetail stems (Equisetum arvense) 10.0%, knotweed grass (Polygonum aviculare) 15.0%, medicinal root lovage (Levisticum officinale), extractant ethanol – 45% v/v); maltodextrin (30 – 40%); excipients: lactose monohydrate, magnesium stearate, microcrystalline cellulose, anhydrous colloidal silicon dioxide; shell: Opadry 200 Green 200F210013 (polyvinyl alcohol – partially hydrolysed, talc, macrogol, quinoline yellow (E 104), titanium dioxide (E 171), indigo carmine (E 132), methacrylic acid copolymer type C, sodium bicarbonate, sunset yellow FCF ( E 110). taste disorders, vomiting, diarrhea, bloating, renal colic, dizziness.Storage conditionsDoes not require special storage conditions.Keep out of the reach of children.Shelf life is 2 years.Do not use the drug after the expiration date indicated on the package.Uronefron tablets p / o No. 10×6 Price for Uronefron tablets p / o No. 10×6 Instructions for use for Uronefron tablets p / o No. 10×6